Therapeutic Approach on AGE-RAGE Interaction and Its Function in Diabetic Inflammation Process
Keywords: AGEs; Amadori's product; CML; DAG-PKC pathway; Diabetes; N-acetylcysteine; N-phenacylthiazolium-bromide; RAGE; amadorins; aminoguanidine; aminosalicyclic acid; antioxidant compounds; arylcarboxilic acid; arylpropane derivative; aspirin; benfotiamine; carboximethyl lysine; chalcone derivative; chondroitin sulfate; cytokines; diacylglycerol-protein kinase C; fluorescent cross-linking species; homopiperazine derivative; hydrazono-oxo-thiazolidine derivatives; ibuprofen; indo-methacin; inflammation; inositol; lipoic acid amide; non-fluorescent and non-cross linking species; para-aminobenzoic acid; patents; pentoxifylline; phenylguanidine; phenylpropeneamid derivative; probucol; pyridazinone derivative; pyridoxamine; synthetic AGE inhibitors; thiourea
Document Type: Research Article
Publication date: 01 November 2010
- Recent Patents on Endocrine, Metabolic & Immune Drug Discovery publishes review articles by experts on recent patents in the field of endocrine, metabolic and immune drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in endocrine, metabolic and immune drug design and discovery.
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content